(Q24198068)

English

Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease

scientific article

In more languages

edit

Statements

0 references

0 references

Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease (English)

0 references

main subject

chronic obstructive pulmonary disease

0 references

1 reference

Leanne Cheyne

1

0 references

Melanie J Irvin-Sellers

series ordinal

2

0 references

John White

series ordinal

3

0 references

publication date

16 September 2013

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

The pharmacological properties of tiotropium

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

Tiotropium for stable chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

Cardiovascular safety of tiotropium in patients with COPD.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

Tiotropium HandiHaler in the treatment of COPD: a safety review

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

Meta-analysis: anticholinergics, but not beta-agonists, reduce severe exacerbations and respiratory mortality in COPD.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

Tiotropium for treatment of stable COPD: a meta-analysis of clinically relevant outcomes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

21 January 2018

Tiotropium mist inhaler for COPD increases risk of mortality compared with placebo

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-acting bronchodilators in COPD

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular events associated with ipratropium bromide in COPD.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD009552.PUB2

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD009552.PUB2

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3414783

OpenCitations bibliographic resource ID

3414783

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3414783

PubMed publication ID

24043433

1 reference

stated in

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3414783

(Q24198068)

Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)